Total Payments
$16,593
2024 Payments
$1,899
Companies
35
Transactions
580
Medicare Patients
4,877
Medicare Billing
$319,660
Payment Breakdown by Category
Food & Beverage$12,361 (74.5%)
Other$3,076 (18.5%)
Travel$1,129 (6.8%)
Education$27.87 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,361 | 568 | 74.5% |
| Honoraria | $3,076 | 2 | 18.5% |
| Travel and Lodging | $1,129 | 4 | 6.8% |
| Education | $27.87 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EPI Health, LLC | $4,848 | 14 | $0 (2022) |
| ABBVIE INC. | $2,237 | 82 | $0 (2024) |
| PFIZER INC. | $1,008 | 68 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,001 | 60 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $821.70 | 48 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $728.39 | 32 | $0 (2024) |
| Lilly USA, LLC | $604.25 | 31 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $509.16 | 24 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $480.47 | 18 | $0 (2023) |
| Dermavant Sciences, Inc. | $472.12 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,899 | 91 | Dermavant Sciences, Inc. ($275.60) |
| 2023 | $1,642 | 80 | AbbVie Inc. ($360.76) |
| 2022 | $1,452 | 67 | ABBVIE INC. ($415.00) |
| 2021 | $1,762 | 101 | AbbVie Inc. ($226.88) |
| 2020 | $1,550 | 97 | Galderma Laboratories, L.P. ($185.22) |
| 2019 | $6,426 | 77 | EPI Health, LLC ($4,738) |
| 2018 | $862.14 | 36 | Galderma Laboratories, L.P. ($294.83) |
| 2017 | $1,001 | 31 | AbbVie, Inc. ($387.58) |
All Payment Transactions
580 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $34.79 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.86 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $80.72 | General |
| 11/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $108.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.28 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: DERMATOLOGY | ||||||
| 10/31/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Inflammation & Immunology | ||||||
| 10/17/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: DERMATOLOGY | ||||||
| 10/03/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Dermatology | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.85 | General |
| Category: Immunology | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.39 | General |
| Category: Immunology | ||||||
| 09/20/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: Inflammation & Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,190 | 1,810 | $372,490 | $79,573 |
| 2022 | 13 | 1,225 | 1,887 | $368,030 | $77,203 |
| 2021 | 15 | 1,368 | 2,038 | $369,235 | $90,432 |
| 2020 | 15 | 1,094 | 1,445 | $256,547 | $72,450 |
Total Patients
4,877
Total Services
7,180
Medicare Billing
$319,660
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 372 | 502 | $133,381 | $30,154 | 22.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 186 | 232 | $74,240 | $18,228 | 24.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 183 | 229 | $43,510 | $8,678 | 19.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 86 | 97 | $33,950 | $6,123 | 18.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 72 | 72 | $23,688 | $5,083 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 57 | $19,095 | $4,675 | 24.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 126 | 474 | $25,596 | $2,246 | 8.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 52 | 56 | $7,840 | $2,173 | 27.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 39 | 39 | $8,303 | $1,693 | 20.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 12 | 13 | $2,730 | $489.45 | 17.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 39 | $156.00 | $30.71 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 353 | 486 | $122,548 | $28,367 | 23.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 202 | 238 | $76,160 | $17,214 | 22.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 181 | 235 | $44,650 | $8,055 | 18.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 88 | $29,480 | $7,246 | 24.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 75 | 75 | $22,140 | $4,125 | 18.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 55 | 59 | $20,650 | $3,947 | 19.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 64 | 70 | $9,800 | $2,419 | 24.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 123 | 489 | $26,406 | $2,252 | 8.5% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 15 | 15 | $4,700 | $1,097 | 23.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 21 | 21 | $4,303 | $966.29 | 22.5% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 15 | 15 | $3,750 | $864.77 | 23.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 17 | 19 | $3,135 | $586.94 | 18.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 30 | 77 | $308.00 | $62.57 | 20.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 376 | 503 | $119,465 | $31,932 | 26.7% |
About Dr. Richard Assaf, MD
Dr. Richard Assaf, MD is a Pediatric Dermatology healthcare provider based in Westlake, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669421392.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Assaf, MD has received a total of $16,593 in payments from pharmaceutical and medical device companies, with $1,899 received in 2024. These payments were reported across 580 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($12,361).
As a Medicare-enrolled provider, Assaf has provided services to 4,877 Medicare beneficiaries, totaling 7,180 services with total Medicare billing of $319,660. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatric Dermatology
- Other Specialties Procedural Dermatology, Dermatology
- Location Westlake, OH
- Active Since 05/09/2006
- Last Updated 06/16/2021
- Taxonomy Code 207NP0225X
- Entity Type Individual
- NPI Number 1669421392
Products in Payments
- Sitavig (Drug) $4,781
- DUPIXENT (Biological) $929.68
- EUCRISA (Drug) $748.90
- Humira (Biological) $697.08
- RINVOQ (Biological) $584.48
- SKYRIZI (Biological) $543.66
- TALTZ (Drug) $477.43
- VTAMA (Drug) $472.12
- COSENTYX (Biological) $445.29
- Sotyktu (Drug) $365.21
- SOOLANTRA (Drug) $351.39
- ENSTILAR (Drug) $315.12
- Seysara (Drug) $301.26
- REMICADE (Biological) $279.64
- OPZELURA (Drug) $275.20
- ORACEA (Drug) $260.33
- Winlevi (Drug) $252.47
- CIBINQO (Drug) $214.09
- DUOBRII (Drug) $194.86
- SPEVIGO (Drug) $194.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.